On June 20, 2026, the company’s shareholders decided to appoint Ms. Lai Jun (Jessica), a shareholder of the company, as the general manager of Chongqing Bull Biopharmaceutical Co., Ltd. for a term of 5 years. Ms. Lai Jun will be fully responsible for all business operations of the company and will have the authority to make decisions on the company’s personnel, business scope, customer relations, product types and revenue distribution.